A phase 3 clinical trial of duloxetine in children and adolescents with depressive disorder
Phase 3
Completed
- Conditions
- Depressive disorder
- Registration Number
- JPRN-jRCT2080223678
- Lead Sponsor
- Shionogi & Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 149
Inclusion Criteria
Patients who diagnosed with major depressive disorder or persistent depressive disorder as defined by Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and completely meet the criteria of major depressive episode. And et al.
Exclusion Criteria
Patients who have allergies to two or more medicines or have a history of severe allergic reactions with medicines. Patients who have participated in a clinical study or a clinical investigation of duloxetine and have previously received study drugs. And et al.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method